November 18, 2009 - Pancreatic cancer remains one of the deadliest cancers, with a prognosis of just six months to live, and less than 5 percent surviving to five years after diagnosis. While there is available treatment using gemcitabine, sold as Gemzar, it has a response rate of only 5 percent.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now